Natpara

Chemical Nameparathyroid hormone
Dosage FormInjection (subcutaneous; 25 mcg, 50 mcg, 75 mcg, 100 mcg)
Drug ClassHormones
SystemEndocrine
CompanyNPS Pharms Inc
Approval Year2015

Indication

  • To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism.
Last updated on 10/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Natpara (parathyroid hormone) Prescribing Information 2018Shire-NPS Pharmaceuticals, Inc., Lexington, MA